Feds, Nobel Prize Winner Back Sanofi At High Court IP Fight
The federal government, various drug companies and a molecular biologist who won the Nobel Prize for his work with monoclonal antibodies urged the U.S. Supreme Court to keep the standard of...To view the full article, register now.
Already a subscriber? Click here to view full article